Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: BIOLOGICAL: palivizumab|DRUG: ribavirin
Sponsor: Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)